Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is 10.00% vs -10.11% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 29.63% vs 0.00% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 55.07% vs -5.11% in Mar 2024
Compare Balance Sheet Results of Ishita Drugs
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
2.99
13.97
-10.98
-78.60%
Share Warrants & Outstandings
Total Reserve
7.80
11.46
-3.66
-31.94%
Shareholder's Funds
10.79
25.43
-14.64
-57.57%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.09
0.00
0.09
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.09
0.00
0.09
0.00%
Deferred Tax Assets / Liabilities
0.01
-0.05
0.06
120.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.10
-0.05
0.15
300.00%
Current Liabilities
Trade Payables
0.95
0.00
0.95
0.00%
Other Current Liabilities
0.46
0.00
0.46
0.00%
Short Term Borrowings
3.81
0.16
3.65
2,281.25%
Short Term Provisions
0.18
0.00
0.18
0.00%
Total Current Liabilities
5.40
0.17
5.23
3,076.47%
Total Liabilities
16.30
25.55
-9.25
-36.20%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
4.84
0.06
4.78
7,966.67%
Less: Accumulated Depreciation
3.96
0.06
3.90
6,500.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.88
0.00
0.88
0.00%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.35
21.36
-21.01
-98.36%
Long Term Loans & Advances
0.08
1.28
-1.20
-93.75%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
1.31
22.64
-21.33
-94.21%
Current Assets Loans & Advances
Current Investments
3.52
0.00
3.52
0.00%
Inventories
4.46
0.00
4.46
0.00%
Sundry Debtors
1.90
0.00
1.90
0.00%
Cash and Bank
4.83
2.86
1.97
68.88%
Other Current Assets
0.03
0.00
0.03
0.00%
Short Term Loans and Advances
0.24
0.05
0.19
380.00%
Total Current Assets
14.98
2.91
12.07
414.78%
Net Current Assets (Including Current Investments)
9.58
2.74
6.84
249.64%
Total Current Assets Excluding Current Investments
11.47
2.91
8.56
294.16%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
16.30
25.55
-9.25
-36.20%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
3.90
0.16
3.74
2,337.50%
Book Value per share (adjusted)
36.08
18.20
17.88
98.24%
Annual - Borrowings
Borrowings 3.90 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 0.88 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 10.00% vs -10.11% in Mar 2024
Annual - Investments
Investments 0.35 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 29.63% vs 0.00% in Mar 2024
Annual - Current Assets
Current Assets 14.98 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 55.07% vs -5.11% in Mar 2024






